Novocure (NVCR) Tops Q3 EPS by 1c

Novocure (NASDAQ: NVCR) reported Q3 EPS of ($0.25), $0.01 better than the analyst estimate of ($0.26). Revenue for the quarter came in at $130.99 million versus the consensus estimate of $132.42 million.

For earnings history and earnings-related data on Novocure (NVCR) click here.

You May Also Be Interested In

• NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
• Novocure’s Optune Pax® Receives CE Mark for the Treatment of Locally Advanced Pancreatic Cancer
• Corona-maker Constellation Brands beats estimates, shares jump 2%